Opioid sparing anesthesia in patients with liver cirrhosis undergoing liver resection: a controlled randomized double-blind study

Abstract Objective Opioid metabolism and pharmacodynamics may be affected in hepatic patients. Ketamine and dexmedetomidine are conventional anesthetics used in our daily practice. The opioid-sparing effects of this combination have not been evaluated in patients with liver cirrhosis undergoing live...

Full description

Saved in:
Bibliographic Details
Main Authors: Eman Sayed Ibrahim, Ahmed A. Metwally, Mohamed Abdullatif, Essam A. Eid, Mahmoud G. Mousa, Amany A. Sultan
Format: Article
Language:English
Published: BMC 2025-02-01
Series:BMC Anesthesiology
Subjects:
Online Access:https://doi.org/10.1186/s12871-025-02915-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571398973816832
author Eman Sayed Ibrahim
Ahmed A. Metwally
Mohamed Abdullatif
Essam A. Eid
Mahmoud G. Mousa
Amany A. Sultan
author_facet Eman Sayed Ibrahim
Ahmed A. Metwally
Mohamed Abdullatif
Essam A. Eid
Mahmoud G. Mousa
Amany A. Sultan
author_sort Eman Sayed Ibrahim
collection DOAJ
description Abstract Objective Opioid metabolism and pharmacodynamics may be affected in hepatic patients. Ketamine and dexmedetomidine are conventional anesthetics used in our daily practice. The opioid-sparing effects of this combination have not been evaluated in patients with liver cirrhosis undergoing liver resection. We aimed to investigate the potential peri-operative opioid-sparing effects of intra-operative dexmedetomidine and ketamine infusions in patients with Child A liver cirrhosis undergoing liver resection. Methods This study was a randomized controlled double-blind trial. 92 adult patients of both sex with Child class (A) liver cirrhosis aged 18 to 65 years entering and completing the study. We excluded patients with renal or cardiac dysfunction or contraindications from study medications.46 patients in the opioid-sparing group (OS) receiving ketamine and dexmedetomidine infusions and 46 patients in the opioid-based (OB) group as controls. The main outcome measures: were intra-operative fentanyl requirements, postoperative fentanyl requirements, visual analogue pain scores, postoperative nausea, vomiting, ileus, desaturation, intra-operative hemodynamic events, and ICU stay were recorded. Results The total intra-operative fentanyl consumption was significantly lower in the OS group compared with the OB group, 183.2 ± 35.61 µg and 313.5 ± 75.06 µg, respectively, P < 0.001. The postoperative 1st 48 h fentanyl consumption was significantly lower in the OS group compared with the OB group, 354.5 ± 112.62 µg and 779.1 ± 294.97 ± µg, respectively, P < 0.001. Visual analogue scores were significantly better in the OS group at the early 2-hour assessment point postoperatively. The postoperative adverse events were significantly more frequent in the opioid-based group. ICU stay was significantly shorter in the OS group. Conclusions Administering dexmedetomidine and ketamine infusions intra-operatively to patients with Child A liver cirrhosis undergoing liver resection resulted in notable opioid-sparing effects, with reductions of approximately 40% intra-operatively and 55% postoperatively. The opioid-sparing group exhibited improved postoperative outcomes, including reduced pain, decreased incidence of opioid-related side effects and shorter ICU stays.
format Article
id doaj-art-afffe43073b443f5bfde91c610d0ea6d
institution Kabale University
issn 1471-2253
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series BMC Anesthesiology
spelling doaj-art-afffe43073b443f5bfde91c610d0ea6d2025-02-02T12:39:56ZengBMCBMC Anesthesiology1471-22532025-02-012511910.1186/s12871-025-02915-4Opioid sparing anesthesia in patients with liver cirrhosis undergoing liver resection: a controlled randomized double-blind studyEman Sayed Ibrahim0Ahmed A. Metwally1Mohamed Abdullatif2Essam A. Eid3Mahmoud G. Mousa4Amany A. Sultan5Department of Anaesthesiology, Intensive Care and Pain Management, National Liver Institute – Menoufia UniversityDepartment of Anaesthesiology, Intensive Care and Pain Management, Faculty of Medicine, Menoufia UniversityDepartment of Anaesthesiology and Surgical Intensive Care, Faculty of Medicine, Cairo UniversityDepartment of Anaesthesiology, Intensive Care and Pain Management, National Liver Institute – Menoufia UniversityDepartment of Anaesthesiology, Intensive Care and Pain Management, National Liver Institute – Menoufia UniversityDepartment of Anaesthesiology, Intensive Care and Pain Management, Faculty of Medicine, Menoufia UniversityAbstract Objective Opioid metabolism and pharmacodynamics may be affected in hepatic patients. Ketamine and dexmedetomidine are conventional anesthetics used in our daily practice. The opioid-sparing effects of this combination have not been evaluated in patients with liver cirrhosis undergoing liver resection. We aimed to investigate the potential peri-operative opioid-sparing effects of intra-operative dexmedetomidine and ketamine infusions in patients with Child A liver cirrhosis undergoing liver resection. Methods This study was a randomized controlled double-blind trial. 92 adult patients of both sex with Child class (A) liver cirrhosis aged 18 to 65 years entering and completing the study. We excluded patients with renal or cardiac dysfunction or contraindications from study medications.46 patients in the opioid-sparing group (OS) receiving ketamine and dexmedetomidine infusions and 46 patients in the opioid-based (OB) group as controls. The main outcome measures: were intra-operative fentanyl requirements, postoperative fentanyl requirements, visual analogue pain scores, postoperative nausea, vomiting, ileus, desaturation, intra-operative hemodynamic events, and ICU stay were recorded. Results The total intra-operative fentanyl consumption was significantly lower in the OS group compared with the OB group, 183.2 ± 35.61 µg and 313.5 ± 75.06 µg, respectively, P < 0.001. The postoperative 1st 48 h fentanyl consumption was significantly lower in the OS group compared with the OB group, 354.5 ± 112.62 µg and 779.1 ± 294.97 ± µg, respectively, P < 0.001. Visual analogue scores were significantly better in the OS group at the early 2-hour assessment point postoperatively. The postoperative adverse events were significantly more frequent in the opioid-based group. ICU stay was significantly shorter in the OS group. Conclusions Administering dexmedetomidine and ketamine infusions intra-operatively to patients with Child A liver cirrhosis undergoing liver resection resulted in notable opioid-sparing effects, with reductions of approximately 40% intra-operatively and 55% postoperatively. The opioid-sparing group exhibited improved postoperative outcomes, including reduced pain, decreased incidence of opioid-related side effects and shorter ICU stays.https://doi.org/10.1186/s12871-025-02915-4OSALiver cirrhosisLiver resection
spellingShingle Eman Sayed Ibrahim
Ahmed A. Metwally
Mohamed Abdullatif
Essam A. Eid
Mahmoud G. Mousa
Amany A. Sultan
Opioid sparing anesthesia in patients with liver cirrhosis undergoing liver resection: a controlled randomized double-blind study
BMC Anesthesiology
OSA
Liver cirrhosis
Liver resection
title Opioid sparing anesthesia in patients with liver cirrhosis undergoing liver resection: a controlled randomized double-blind study
title_full Opioid sparing anesthesia in patients with liver cirrhosis undergoing liver resection: a controlled randomized double-blind study
title_fullStr Opioid sparing anesthesia in patients with liver cirrhosis undergoing liver resection: a controlled randomized double-blind study
title_full_unstemmed Opioid sparing anesthesia in patients with liver cirrhosis undergoing liver resection: a controlled randomized double-blind study
title_short Opioid sparing anesthesia in patients with liver cirrhosis undergoing liver resection: a controlled randomized double-blind study
title_sort opioid sparing anesthesia in patients with liver cirrhosis undergoing liver resection a controlled randomized double blind study
topic OSA
Liver cirrhosis
Liver resection
url https://doi.org/10.1186/s12871-025-02915-4
work_keys_str_mv AT emansayedibrahim opioidsparinganesthesiainpatientswithlivercirrhosisundergoingliverresectionacontrolledrandomizeddoubleblindstudy
AT ahmedametwally opioidsparinganesthesiainpatientswithlivercirrhosisundergoingliverresectionacontrolledrandomizeddoubleblindstudy
AT mohamedabdullatif opioidsparinganesthesiainpatientswithlivercirrhosisundergoingliverresectionacontrolledrandomizeddoubleblindstudy
AT essamaeid opioidsparinganesthesiainpatientswithlivercirrhosisundergoingliverresectionacontrolledrandomizeddoubleblindstudy
AT mahmoudgmousa opioidsparinganesthesiainpatientswithlivercirrhosisundergoingliverresectionacontrolledrandomizeddoubleblindstudy
AT amanyasultan opioidsparinganesthesiainpatientswithlivercirrhosisundergoingliverresectionacontrolledrandomizeddoubleblindstudy